Levonorgestrel News and Research

RSS
Women & Infants Hospital physician to study treatment options for heavy menstrual bleeding

Women & Infants Hospital physician to study treatment options for heavy menstrual bleeding

FDA approves Teva's Quartette tablets for prevention of pregnancy

FDA approves Teva's Quartette tablets for prevention of pregnancy

Mirena coil intrauterine device a better treatment for heavy menstrual periods

Mirena coil intrauterine device a better treatment for heavy menstrual periods

IUD insertion does not increase risk of pelvic inflammatory disease in women

IUD insertion does not increase risk of pelvic inflammatory disease in women

Drospirenone-containing birth control pills associated with increased risk of blood clots

Drospirenone-containing birth control pills associated with increased risk of blood clots

Transvaginal ultrasound effective in treating early-stage endometrial cancer

Transvaginal ultrasound effective in treating early-stage endometrial cancer

Contraceptive patch suppresses ovulation in obese, nonobese women

Contraceptive patch suppresses ovulation in obese, nonobese women

FDA accepts Teva's NDA for Quartette oral contraceptive

FDA accepts Teva's NDA for Quartette oral contraceptive

FDA approves Watson's ANDA for Next Choice ONE DOSE emergency contraceptive

FDA approves Watson's ANDA for Next Choice ONE DOSE emergency contraceptive

Teva announces new data from women's health franchise

Teva announces new data from women's health franchise

Bayer announces updated labels for drospirenone-containing COCs in the U.S.

Bayer announces updated labels for drospirenone-containing COCs in the U.S.

Morning after pills difficult for teenagers to procure

Morning after pills difficult for teenagers to procure

HHS: Plan B access will stay limited

HHS: Plan B access will stay limited

Watson introduces Amethia Lo and ethinyl estradiol tablets

Watson introduces Amethia Lo and ethinyl estradiol tablets

Oral hormonal contraceptives linked to blood clots: Study

Oral hormonal contraceptives linked to blood clots: Study

FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives

FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Watson Pharmaceuticals confirms SEASONIQUE patent challenge

Safety of birth control pills under scrutiny

Safety of birth control pills under scrutiny

Birth control pill safety issues raised

Birth control pill safety issues raised

Sosei to introduce NorLevo oral emergency contraceptive in Japan

Sosei to introduce NorLevo oral emergency contraceptive in Japan